IntelGenx Technologies (CVE:IGX) Shares Up 1.8% – Still a Buy?

IntelGenx Technologies Corp. (CVE:IGX)’s stock price was up 1.8% during mid-day trading on Monday . The company traded as high as C$0.60 and last traded at C$0.58. Approximately 11,848 shares traded hands during trading, a decline of 79% from the average daily volume of 56,279 shares. The stock had previously closed at C$0.57.

IntelGenx Technologies Stock Performance

The company has a current ratio of 2.77, a quick ratio of 2.69 and a debt-to-equity ratio of 164.62. The company has a market cap of C$87.32 million and a PE ratio of -7.44. The firm’s fifty day moving average is C$0.58 and its 200 day moving average is C$0.58.

IntelGenx Technologies Company Profile

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health.